Access the full text.
Sign up today, get DeepDyve free for 14 days.
Guo-xing Wan, Longchao Xiang, Xue Sun, Xuanbin Wang, Hongliang Li, W. Ge, Fengjun Cao (2016)
Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patientsOncotarget, 8
R. Shao, Sherry Taylor, Dennis Oh, L. Schwartz (2015)
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationOncotarget, 6
Meyeon Park, Chi-yuan Hsu, A. Go, H. Feldman, D. Xie, Xiaoming Zhang, T. Mifflin, S. Waikar, V. Sabbisetti, J. Bonventre, J. Coresh, R. Nelson, P. Kimmel, J. Kusek, Mahboob Rahman, J. Schelling, R. Vasan, Kathleen Liu (2017)
Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.Clinical journal of the American Society of Nephrology : CJASN, 12 5
C. Cintin, J. Johansen, I. Christensen, P. Price, S. Sørensen, H. Nielsen (1999)
Serum YKL-40 and colorectal cancerBritish Journal of Cancer, 79
Jeremy Puthumana, Isaac Hall, P. Reese, B. Schröppel, F. Weng, H. Thiessen-Philbrook, M. Doshi, V. Rao, C. Lee, J. Elias, L. Cantley, C. Parikh (2017)
YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation.Journal of the American Society of Nephrology : JASN, 28 2
C. Peralta, R. Katz, J. Bonventre, V. Sabbisetti, D. Siscovick, M. Sarnak, M. Shlipak (2012)
Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).American journal of kidney diseases : the official journal of the National Kidney Foundation, 60 6
Chi-yuan Hsu, D. Xie, S. Waikar, J. Bonventre, Xiaoming Zhang, V. Sabbisetti, T. Mifflin, J. Coresh, C. Diamantidis, Jiang He, C. Lora, E. Miller, R. Nelson, A. Ojo, Mahboob Rahman, J. Schelling, F. Wilson, P. Kimmel, H. Feldman, R. Vasan, Kathleen Liu (2017)
Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.Kidney international, 91 1
Merlin Thomas, M. Brownlee, K. Suszták, K. Sharma, K. Jandeleit-Dahm, S. Zoungas, P. Rossing, P. Groop, M. Cooper (2015)
Diabetic kidney diseaseNature Reviews Disease Primers
F. Persson, P. Rossing (2018)
Diagnosis of diabetic kidney disease: state of the art and future perspective.Kidney international supplements, 8 1
Kathleen Liu, Wei Yang, A. Anderson, H. Feldman, S. Demirjian, T. Hamano, Jiang He, J. Lash, E. Lustigova, S. Rosas, M. Simonson, Kaixiang Tao, Chi-yuan Hsu (2013)
Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney diseaseKidney international, 83
T. Tervaert, A. Mooyaart, K. Amann, A. Cohen, H. Cook, C. Drachenberg, F. Ferrario, A. Fogo, M. Haas, Emile Heer, K. Joh, L. Noël, J. Radhakrishnan, S. Seshan, I. Bajema, J. Bruijn (2010)
Pathologic classification of diabetic nephropathy.Journal of the American Society of Nephrology : JASN, 21 4
G. Tesch (2008)
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.American journal of physiology. Renal physiology, 294 4
G. Nadkarni, V. Rao, F. Ismail-Beigi, V. Fonseca, Sudhir Shah, M. Simonson, L. Cantley, P. Devarajan, C. Parikh, S. Coca (2016)
Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.Clinical journal of the American Society of Nephrology : CJASN, 11 8
N. Cho, N. Cho, J. Shaw, S. Karuranga, Yadi Huang, J. Fernandes, A. Ohlrogge, B. Malanda (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.Diabetes research and clinical practice, 138
L. Fried, N. Emanuele, Jane Zhang, M. Brophy, Todd Conner, W. Duckworth, D. Leehey, P. McCullough, T. O'connor, P. Palevsky, R. Reilly, S. Seliger, S. Warren, Suzanne Watnick, P. Peduzzi, P. Guarino (2013)
Combined angiotensin inhibition for the treatment of diabetic nephropathy.The New England journal of medicine, 369 20
D. Moledina, C. Parikh (2018)
Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine.Seminars in nephrology, 38 1
C. Parikh, E. Abraham, M. Ancukiewicz, C. Edelstein (2005)
Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit.Journal of the American Society of Nephrology : JASN, 16 10
V. Jotwani, Alexandra Lee, M. Estrella, R. Katz, P. Garimella, R. Malhotra, D. Rifkin, W. Ambrosius, B. Freedman, A. Cheung, K. Raphael, P. Drawz, Javier Neyra, S. Oparil, H. Punzi, M. Shlipak, J. Ix (2019)
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney DiseaseAmerican Journal of Nephrology, 49
Meyeon Park, R. Katz, M. Shlipak, Daniel Weiner, Russell Tracy, V. Jotwani, Jan Hughes-Austin, Francis Gabbai, Chi-yuan Hsu, Marc Pfeffer, N. Bansal, A. Bostom, Orlando Gutierrez, M. Sarnak, A. Levey, J. Ix (2017)
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT TrialAmerican Journal of Transplantation, 17
V. Melnikov, Tevfik Ecder, G. Fantuzzi, Britta Siegmund, M. Lucia, C. Dinarello, Robert Schrier, Charles Edelstein (2001)
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure.The Journal of clinical investigation, 107 9
N. Bhavsar, A. Köttgen, J. Coresh, B. Astor (2012)
Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation, 60 2
T. Okada, T. Nagao, H. Matsumoto, Y. Nagaoka, Toshikazu Wada, T. Nakao (2012)
Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuriaNephrology, 17
K. Mori, H. Lee, Dana Rapoport, Ian Drexler, Kirk Foster, Jun Yang, K. Schmidt-Ott, Xia Chen, Jau-yi Li, Stacey Weiss, J. Mishra, F. Cheema, G. Markowitz, T. Suganami, K. Sawai, M. Mukoyama, C. Kunis, V. D’Agati, P. Devarajan, J. Barasch (2005)
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.The Journal of clinical investigation, 115 3
V. Jotwani, R. Katz, J. Ix, O. Gutiérrez, M. Bennett, C. Parikh, S. Cummings, M. Sarnak, M. Shlipak (2018)
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.American journal of kidney diseases : the official journal of the National Kidney Foundation, 72 2
H. Anders, T. Huber, B. Isermann, M. Schiffer (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney diseaseNature Reviews Nephrology, 14
M. Sarnak, R. Katz, A. Newman, T. Harris, C. Peralta, P. Devarajan, M. Bennett, L. Fried, J. Ix, S. Satterfield, E. Simonsick, C. Parikh, M. Shlipak (2014)
Association of urinary injury biomarkers with mortality and cardiovascular events.Journal of the American Society of Nephrology : JASN, 25 7
(2016)
USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Li Yang, C. Brooks, S. Xiao, V. Sabbisetti, M. Yeung, L. Hsiao, T. Ichimura, V. Kuchroo, J. Bonventre (2015)
KIM-1-mediated phagocytosis reduces acute injury to the kidney.The Journal of clinical investigation, 125 4
I. Schmidt, Isaac Hall, S. Kale, Sik Lee, C. He, Yashang Lee, G. Chupp, G. Moeckel, C. Lee, J. Elias, C. Parikh, L. Cantley (2013)
Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function.Journal of the American Society of Nephrology : JASN, 24 2
A. Levey, J. Bosch, J. Lewis, T. Greene, N. Rogers, David Roth (1999)
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 130
J. Ix, R. Katz, N. Bansal, M. Foster, D. Weiner, R. Tracy, V. Jotwani, Jan Hughes-Austin, D. McKay, F. Gabbai, Chi-yuan Hsu, A. Bostom, A. Levey, M. Shlipak (2017)
Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation, 69 3
T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Yoko Saito, T. Yoshioka, Y. Ogawa, Hirotaka Imamaki, T. Kusakabe, K. Ebihara, M. Omata, N. Satoh, A. Sugawara, J. Barasch, K. Nakao (2009)
Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons.Kidney international, 75 3
AbstractIntroduction: Diabetes is a leading cause of end-stage kidney disease (ESKD). Biomarkers of tubular health may prognosticate chronic kidney disease (CKD) progression beyond estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR). Methods: We examined associations of five urinary biomarkers of tubular injury and repair (NGAL, KIM-1, IL-18, MCP-1, YKL-40) with kidney function decline (first occurrence of a decrease in eGFR ≥30 mL/min/1.73 m2 if randomization eGFR ≥60 or ≥50% if randomization eGFR <60; ESKD) and all-cause mortality among 1,135 VA NEPHRON-D trial participants with baseline UACR ≥300 mg/g and available urine samples. Covariates included age, sex, race, BMI, systolic BP, HbA1c, treatment arm, eGFR, and UACR. In a subset of participants with 12-month samples (n = 712), we evaluated associations of KIM-1, MCP-1, and YKL-40 change (from baseline to 12 months) with eGFR decline (from 12 months onward). Results: At baseline, mean age was 65 years, mean eGFR was 56 mL/min/1.73 m2, and median UACR was 840 mg/g. Over a median of 2.2 years, 13% experienced kidney function decline and 9% died. In fully adjusted models, the highest versus lowest quartiles of MCP-1 and YKL-40 were associated with 2.18- and 1.76-fold higher risks of kidney function decline, respectively. One-year changes in KIM-1, MCP-1, and YKL-40 were not associated with subsequent eGFR decline. Higher baseline levels of NGAL, IL-18, MCP-1, and YKL-40 levels (per 2-fold higher) were independently associated with 10–40% higher risk of mortality. Conclusion: Among Veterans with diabetes and CKD, urinary biomarkers of tubular health were associated with kidney function decline and mortality.
American Journal of Nephrology – Karger
Published: Mar 1, 2023
Keywords: Mortality; KIM-1; NGAL; MCP-1; YKL-40; IL-18; Diabetic kidney disease
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.